Perbedaan Vale Indonesia Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Vale Indonesia Tbk. diperdagangkan di Rp5.000 (kapitalisasi pasar 55,6 T, volume 24 jam 11 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp242 (kapitalisasi pasar 164,65 M, volume 24 jam 187,4 rb). Perbedaan utamanya: Vale Indonesia Tbk. jauh lebih besar — sekitar 337,7× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Vale Indonesia Tbk. lebih aktif diperdagangkan (11 jt vs 187,4 rb). Mana yang lebih baik tergantung tujuan investasimu.
| INCO | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 55,6 T | 164,65 M |
Volume | 11 jt | 187,4 rb |
Lot | 110,01 rb | 1,87 rb |
Perputaran | 55,81 M | 44,35 jt |
Harga Rata-rata | 5.072,97 | 236,67 |
Nilai Transaksi | 55,81 M | 44,35 jt |
Harga Ekuilibrium Indikatif | 5.000 | 242 |
Volume Ekuilibrium Indikatif | 6,28 rb | 500 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Vale Indonesia Tbk, formely PT International Nickel Indonesia, was established on July 25, 1968. PT. INCO produces nickel in matte, an intermediate product, from lateritic ores at its integrated mining and processing facilities near Soroako on the island of Sulawesi. The company is owned 58.7 % by Inco Limited of Canada, 20.1 % by Sumitomo Metal Mining Co., Ltd. of Japan.The Company is PMA
Selengkapnya di halaman INCO →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →